Evidence map›Paper›PMID 32390092›Full record

Trial reportClinical oral investigations2020

A randomized, controlled, two-month pilot trial of stannous fluoride dentifrice versus sodium fluoride dentifrice after oxalate treatment for dentinal hypersensitivity.

Chad J Anderson, Gerard Kugel, Yuanshu Zou, Marco Ferrari, Robert Gerlach

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Clinical oral investigations, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 11 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Chad J AndersonDepartment of Prosthodontics and Dental Materials, School of Dental Medicine, University of Siena, Siena, Italy. chadjanderson@sbcglobal.net.
Gerard KugelDepartment of Comprehensive Care, School of Dental Medicine, Tufts University, Boston, MA, USA.
Yuanshu ZouThe Procter & Gamble Company, Mason, OH, USA.
Marco FerrariDepartment of Prosthodontics and Dental Materials, School of Dental Medicine, University of Siena, Siena, Italy.
Robert GerlachThe Procter & Gamble Company, Mason, OH, USA.
Procter & Gamble (United States) · USUniversity of Siena · ITTufts University · US

Funding

Procter and Gamble 0
6 · The paper itself

Abstract

objectivesTo compare the effects of a stannous fluoride dentifrice and a sodium fluoride dentifrice on dentinal hypersensitivity when used with an oxalate-based regimen combining in-office and at-home treatment. MATERIALS AND

methodsIn this single-center, randomized, controlled, double-blind, pilot clinical trial, 30 subjects were professionally treated at baseline with a 3% oxalate/potassium salt solution on up to two target teeth, then randomized 1:1 to either 0.454% stannous fluoride or 0.243% sodium fluoride overlabeled dentifrice. Both groups were given 6 sensitivity strips (3.14% potassium oxalate gel) and a soft, manual toothbrush. Subjects were permitted to apply strips on up to two teeth, up to three times per tooth, at home as desired throughout the study. Dentinal sensitivity (cold air blast challenge) was assessed at baseline, immediately after post-professional treatment, and at day 60 using the Schiff scale and a Visual Analog Scale (VAS).

resultsImmediately after professional oxalate treatment, the overall mean Schiff and VAS score decreased 25.6% and 22.4% from baseline, respectively (p ≤ 0.001 for both). At day 60, further reductions in both mean scores were seen in both groups. There were no significant differences between the groups at day 60. All treatments were well tolerated.

conclusionsIn subjects treated with oxalates for dentinal hypersensitivity, both stannous fluoride and sodium fluoride dentifrices are well tolerated, are feasible for routine use, and do not detract from the desensitizing effects of an in-office and at-home oxalate combination treatment regimen. CLINICAL RELEVANCE: Either stannous fluoride or sodium fluoride dentifrices can be recommended to dentinal hypersensitivity patients who undergo professional oxalate treatment.

Indexed as

DentifricesDentin SensitivityDouble-Blind MethodHumansOxalatesPhosphatesPilot ProjectsSodium FluorideTin FluoridesDentifricesOxalatesPhosphatesSodium FluorideTin FluoridesDentin desensitizing agentsDentin sensitivityOxalatesSodium fluorideStannous fluorideTopical preparation

Identifiers

PMID32390092
PMCPMC7544746
OpenAlexW3021345531

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.